Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 12/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 9/20 | 0.41 |
| ▸ | CASR | P41180 | 2/20 | 0.40 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10505383 | 0.97 | ADRB2 (0.42) | ADRB2ADRB1CASRADRB3MEN1 | |
| SCHEMBL10592973 | 0.89 | CASR (0.49) | ADRB2ADRB1CASRADRB3MEN1 | |
| SCHEMBL10503702 | 0.86 | CYP2D6 (0.49) | ADRB2ADRB1CASRADRB3 | |
| SCHEMBL10592451 | 0.86 | ADRB2 (0.41) | ADRB2ADRB1CASRADRB3MEN1 | |
| SCHEMBL10593339 | 0.86 | ADRB2 (0.47) | ADRB2ADRB1CASRADRB3 | |
| SCHEMBL10592061 | 0.86 | CASR (0.50) | ADRB2ADRB1CASRADRB3MEN1 | |
| SCHEMBL10594588 | 0.86 | CYP2D6 (0.45) | ADRB2ADRB1CASRADRB3MEN1 | |
| SCHEMBL10504063 | 0.85 | HTR1A (0.55) | ADRB2ADRB1CASRADRB3MEN1 | |
| SCHEMBL10503951 | 0.85 | GRK3 (0.40) | ADRB2ADRB1CASRADRB3MEN1 | |
| SCHEMBL10504326 | 0.85 | ADRB2 (0.51) | ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0200915-B1 | AMINOPROPANOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND MEDICINES CONTAINING THEM | Roche Diagnostics GmbH (DE) | 1989-09-27 | — | — | EP | disclosed |
| US-4863949-A | CARDIOVASCULAR DISORDER TREATMENT | BOEHRINGER MANNHEIM GMBH (DE) | 1989-09-05 | — | — | US | disclosed |